The molecular
point of care devices market size has the potential to grow by USD
816.62 million during 2020-2024, and the market’s growth momentum
will decelerate during the forecast period. This report provides a
detailed analysis of the market by application (infectious diseases, oncology,
and others) and geography (North America, Europe, Asia, and ROW). Also, the
report analyzes the market’s competitive landscape. It offers information on
several market vendors, including Abbott Laboratories, bioMérieux SA, Bio-Rad
Laboratories Inc., Credo Biomedical Pte. Ltd., Danaher Corp., F. Hoffmann-La
Roche Ltd., Meridian Bioscience Inc., Oxford Nanopore Technologies Ltd., QIAGEN
N.V., and QuantuMDx Group Ltd.
Market Competitive Analysis
The market is concentrated. Abbott
Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Credo Biomedical Pte.
Ltd., Danaher Corp., F. Hoffmann-La Roche Ltd., Meridian Bioscience Inc.,
Oxford Nanopore Technologies Ltd., QIAGEN N.V., and QuantuMDx Group Ltd. are
some of the major market participants. The increasing prevalence of chronic and
infectious diseases, the rising number of product launches, and the rising
number of m&a activities will offer immense growth opportunities.
However, high costs of mPOC devices and procedures, stringent
regulation and inaccuracy of mPOC diagnosis, and lack of skilled
technicians in developing countries may impede the market growth. To make
the most of the opportunities, vendors should focus on growth prospects in the
fast-growing segments, while maintaining their positions in the slow-growing
segments.
To help clients improve their market position, this
molecular point of care devices market forecast report provides a detailed
analysis of the market leaders. It offers information on the competencies and
capacities of these companies. The report also covers details on the market’s
competitive landscape and provides information on the products offered by
various companies. Moreover, this molecular point of care devices market
analysis report provides information on the upcoming trends and challenges that
will influence market growth. This will help companies create strategies to
make the most of future growth opportunities.
This report provides information on the production,
sustainability, and prospects of several leading companies, including:
- Abbott Laboratories
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Credo Biomedical Pte. Ltd.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Meridian Bioscience, Inc.
- Oxford Nanopore Technologies Ltd.
- QIAGEN N.V.
- QuantuMDx Group Ltd.
No comments:
Post a Comment